ACCEL Lite: Selecting an Oral P2Y12 Inhibitor Post-MI: What’s the Best Choice?

<p>In this interview, Francesco Franchi, MD and Spencer B. King III, MD, MACC, with Matt A. Cavender MD, MPH, FACC, discuss how to make the best choice when selecting an oral P2Y12 inhibitor post-MI.</p>